However, CENPT mutations did not affect the IC50 values of docetaxel in both MDA-MB-231 and BT-549 cells, and neither CDKAL1 nor CENPT mutations affected the sensitivity of BC cells to epirubicin in the cell lines tested (Additional file 1: Fig. S9E). This evidence concerns the gene CDKAL1 and breast cancer.